Huntington’s disease breakthrough ‘is like winning the lottery 10 times over’

Gemma Botting, Huntington’s treatment this week, seeing the news about the treatment of Huntington burst into tears.

“I should have cried for three hours. Then the kids came home from school and showed my daughter the BBC story and drowned in tears.”

Gemma’s husband Matt was diagnosed with Huntington’s disease in 2011. The situation is similar to the combination of dementia, Parkinson and motor neuron disease (MND) and normally deadly in twenty years after symptoms are shown. Matt became symptomatic two years ago.

No treatment until now. But on Wednesday Researchers reported how a new gene therapy has managed to slow down the progress of the disease by 75%.

“Like winning the lottery 10 times, Gem says Gemma, 45.

Living with Matt and two children Amelie and 11 -year -old Hugo, Gemma, just outside Swindon, says they are trying to make the best use of together.

When the diagnosis was made, they took a break from their work in the logistics sector to travel the world. “We went for a year – we took all our holidays at once before having children,” Gemma says.

But even having a child was something that took some strolls. They decided that they wanted to scan the gene that caused the disease. There were two options – there is either an IVF version where it was tested for the gene before implantation or naturally conceived and tested the developing embryo.

They have chosen the latter, but to be suitable for these couples, if the test is positive, it should accept to cancel the fetus as in the second pregnancies.

He continued: “We thought carefully what we wanted to do. Huntington’s community does not agree to scan it. But we both knew that we did not want our children to grow with the possibility of having this gene. A very cruel, ruthless illness.”

Now 43 -year -old Matt can still walk, but he has become incompetent with his movement and was also mentally affected.

“There are angry bursts and there is no completely empathy.

Matt no longer works, and when his symptoms began to develop, he had to retire for health reasons.

“We are lucky in some angles, exceeded 40, without symptoms, Gem says Gemma. “He died of illness when his mother was 40 years old. And now there is a possibility of treatment. We have hope where there is no hope.”

He says this is a feeling to be felt by the entire community of Huntington’s disease.

“I work as a consultant in the evening, I usually work with people with Huntington disease. Partially I have trained to give something to the community, and Matt is no longer won, we need money.

“I support people immediately after being tested. Depression is the most common issue because they think everything is lost. So the news about treatment is very important. Everyone will give everyone an elevator.”

“Our neighbors and friends even talk about donation collection, so that we can pay for treatment. I hope it is presented quickly in NHS.”

Of course, this is the question of the minds of everyone affected by the disease.

The BBC contacted with others who lost a large number of families and loved ones who lost all generations to the disease, because they could not encounter an inevitable decline following the diagnosis.

Dave 73 -year -old from West Midlands lost his wife to Huntington. His son is now concerned that he may have the disease and have been transferred to the grandson of the gene.

“It is terrible to see your loved ones suffer, or he says. “This treatment is needed desperately in NHS.”

It is not yet clear whether treatment is available and how fast it will be.

The company behind the therapy, Uniqure, said that in the first quarter of 2026, he will apply for a license in the USA.

If the regulators assess this and confirm the use, the UK Regulator, Drugs and Health Regulatory Agency (MHRA) may force their work and pass through a quick regulatory process.

However, this is just to decide whether it is safe and effective. Another body will be the National Institute of Health and Care Excellence (NICE) to decide whether to use it in NHS in the UK and Wales. A separate organ makes this calculation for Scotland.

It will be expensive as a gene therapy containing neurosurgery. However, the resources in Nice say that this is not necessarily an agreement. One sickle cell therapy The cost of this is 1.65 million per patient and Haemophilia b One This cost was already supported by the health evaluation body of £ 2.6 million.

The sources there, Huntington’s therapy, the first half of the early 2027 can be expected to be expected to be approved, he said.

But if it’s just everything is going smoothly – and there’s more obstacles to overcome.

So far, only the title findings have been published. Scientists say that the entire study should be published and evaluated by independent experts to accurately evaluate what is achieved.

The study was also relatively small – there were only 29 participants followed for 36 months. This is not unusual for gene therapies, and others brought it to NHS after small -scale trials. Considering that there is no existing treatment option for the disease, this cases of treatment is particularly strong.

However, even if this therapy is licensed, it will help only a small part of Huntington’s disease patients because it is aimed at those with or have not yet developed. The complex nature of the surgery also means that only expert centers can do so.

Some scientists pointed out that the benefits will continue in the long run yet.

However, Prof. David Rubinsztein, Deputy Director of Cambridge Medical Research Institute, says that the scale of this breakthrough should not be underestimated.

If it offers “real hope” for this destructive disease, and if the approach is successfully confirmed in the coming months, other neurodegenerative diseases may even have a wider effects on the treatment of Parkinson’s disease and MND.

Gemma appreciates that it was still a way before Matt’s use, but for a long time it may be optimistic about the future for the first time.

“This is like a dream – I can start thinking about aging with my husband. This means the world for me and my children.”

Huntington’s disease causes an error called Huntingtin gene in some of our DNA.

If one of your parents has Huntington’s disease, you have the chance to inherit the modified gene and eventually develop Huntington.

This mutation makes a normal protein in the brain – a neuron killer – called hunting protein.

The aim of the treatment is to permanently reduce the levels of this toxic protein at a single dose.

Therapy uses the latest genetic drug that combines gene treatment and gene silence technologies.